Sertraline-Induced Diplopia

Diplopia is a condition that involves seeing double and impairs quality of life. Acute diplopia can be seen with some general medical drugs and psychotropic drugs. Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed to treat a variety of psychiatric disorders. Sertraline is a relatively selective serotonin reuptake inhibitor with some dopamine reuptake inhibitor activity. This paper reports development of diplopia, a rare adverse effect of SSRI, in a 14 years old patient with major depressive disorder following use of sertraline. Clinicians should keep in mind that diplopia may occur with sertraline treatment.